SF (141 or 282 μmol/kg/day for 4 months) has also been shown to protect against Aβ-induced neurotoxicity in primary mouse neurons and suppress tau protein phosphorylation in a transgenic AD mouse model (67). This evidence concerns the gene MAPT and Alzheimer disease.